Not yet a member?
Here’s a podcast from the webinar presentation earlier this month by our beloved Dr. Weiss, covering the open question of whether we should consider giving an EGFR inhibitor like Tarceva (erlotinib) as an adjuvant (post-operative) therapy following potentially curative surgery for early stage NSCLC. It’s a setting in which there is a good rationale if [...]
Podcast: Play in new window | Download
4 CommentsHere is the last of three interesting cases I discussed with Drs. Alex Farivar, thoracic surgeon at Swedish Cancer Institute here in Seattle, and Anne Tsao, medical oncologist at MD Anderson Cancer Center in Houston. This particular case is a man I saw a few years ago, with a solitary brain lesion and what otherwise [...]
Podcast: Play in new window | Download
0 CommentsHere’s a webinar case discussion I did with Drs. Julie Brahmer from Johns Hopkins in Baltime, and Greg Riely from Memorial Sloan Kettering Cancer Center in New York. They’re great thoracic oncologists as wellas friends, and they were kind enough to join me for discussion of several complex cases that don’t have clear answers and [...]
Podcast: Play in new window | Download
5 Comments Here’s the podcast of the Q&A portion of the excellent webinar with Dr. Pennell on Molecular Markers in Management of NSCLC.
dr-pennell-molecular-markers-qa-audio-podcast
dr-pennell-molecular-markers-qa-transcript
dr-pennell-molecular-markers-qa-figures
Podcast: Play in new window | Download
0 CommentsThis is part 2 of my round table case discussion with Dr. Anne Tsao, a medical oncologist and thoracic oncology expert from MD Anderson Cancer Center in Houston, and Dr. Alex Farivar, a thoracic surgeon with expert training in mesothelioma at Swedish Cancer Institute in Seattle. This particular case covers a patient with a mesothelioma, [...]
Podcast: Play in new window | Download
0 CommentsLast week, Dr. Ross Camidge from the University of Colorado joined me on a webinar entitled “One Size Does Not Fit All” in which he discussed the early work on ALK rearrangements and the novel agent PF-02341066 (now known as crizotinib) in particular, and the new era of molecularly defined practice of oncology in [...]
Podcast: Play in new window | Download
10 CommentsThat short month of February makes it so that March really sneaks up on you! We’re just a few days from March and our first of several upcoming webinars I need to tell people about.
The first will actually be on Monday, March 1st (just 4 days from now), with Dr. Jared Weiss from University of [...]
This is the first part of a case presentation I did with two great colleagues: Dr. Anne Tsao, who is a medical oncologist and lung cancer expert at MD Anderson Cancer Center in Houston, and Dr. Alex Farivar, who is a terrific thoracic surgeon at my own institution, Swedish Cancer Institute in Seattle.
This case is [...]
Podcast: Play in new window | Download
0 CommentsI just wanted to offer a reminder that Dr. Ross Camidge, medical oncologist and lung cancer expert from the University of Colorado in Denver, is going to be speaking with me during a webinar this Wednesday, 2/17, at 8 PM EST/5 PM PST. Among the topics we’ll cover is the EML4-ALK translocation, which is widely [...]
10 CommentsWe know that many people interested in the topics we discuss in our webinars may not be able to attend the live programs, but we’re committed to offering our content to people as easily as possible. Accordingly, here is the podcast version of Dr. Pennell’s very well received presentation on a range of molecular [...]
Podcast: Play in new window | Download
0 Comments